Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alkermes appoints Mark Stejbach CCO

This article was originally published in Scrip

Executive Summary

Biopharmaceutical company Alkermes has appointed Mark Stejbach its first chief commercial officer. Mr Stejbach most recently served as chief commercial officer at Tengion, and was previously vice-president of managed care marketing at Merck & Co. He has 25 years' experience in sales and marketing in the biotech and pharmaceutical industries.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC016530

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel